These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


164 related items for PubMed ID: 9662143

  • 1. Bidirectional modulation of AMPA receptor properties by exogenous phospholipase A2 in the hippocampus.
    Chabot C, Gagné J, Giguère C, Bernard J, Baudry M, Massicotte G.
    Hippocampus; 1998; 8(3):299-309. PubMed ID: 9662143
    [Abstract] [Full Text] [Related]

  • 2. Melittin increases AMPA receptor affinity in rat brain synaptoneurosomes.
    Bernard J, Chabot C, Gagné J, Baudry M, Massicotte G.
    Brain Res; 1995 Feb 13; 671(2):195-200. PubMed ID: 7743208
    [Abstract] [Full Text] [Related]

  • 3. AMPA receptor modulation in previously frozen mouse brain sections: opposite effects of calcium in the cortex and hippocampus.
    Lapierre L, Valastro B, Miceli D, Massicotte G.
    Hippocampus; 2000 Feb 13; 10(6):645-53. PubMed ID: 11153710
    [Abstract] [Full Text] [Related]

  • 4. Involvement of the 12-lipoxygenase pathway of arachidonic acid metabolism in homosynaptic long-term depression of the rat hippocampus.
    Normandin M, Gagné J, Bernard J, Elie R, Miceli D, Baudry M, Massicotte G.
    Brain Res; 1996 Aug 19; 730(1-2):40-6. PubMed ID: 8883886
    [Abstract] [Full Text] [Related]

  • 5. Modulation of DL-alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid/quisqualate receptors by phospholipase A2: a necessary step in long-term potentiation?
    Massicotte G, Vanderklish P, Lynch G, Baudry M.
    Proc Natl Acad Sci U S A; 1991 Mar 01; 88(5):1893-7. PubMed ID: 1848014
    [Abstract] [Full Text] [Related]

  • 6. AMPA receptor phosphorylation is selectively regulated by constitutive phospholipase A(2) and 5-lipoxygenase activities.
    Ménard C, Valastro B, Martel MA, Chartier E, Marineau A, Baudry M, Massicotte G.
    Hippocampus; 2005 Mar 01; 15(3):370-80. PubMed ID: 15630695
    [Abstract] [Full Text] [Related]

  • 7. Modulation of DL-alpha-amino-3-hydroxy-5-methylisoxazole-4-propionate (AMPA)/quisqualate receptors by phospholipase A2 treatment.
    Massicotte G, Baudry M.
    Neurosci Lett; 1990 Oct 16; 118(2):245-8. PubMed ID: 2177177
    [Abstract] [Full Text] [Related]

  • 8. Phospholipase A2 modulates different subtypes of excitatory amino acid receptors: autoradiographic evidence.
    Catania MV, Hollingsworth Z, Penney JB, Young AB.
    J Neurochem; 1993 Jan 16; 60(1):236-45. PubMed ID: 7678040
    [Abstract] [Full Text] [Related]

  • 9. Developmental changes in depolarization-mediated AMPA receptor modifications and potassium-induced long-term potentiation.
    Chabot C, Bernard J, Normandin M, Ohayon M, Baudry M, Massicotte G.
    Brain Res Dev Brain Res; 1996 May 31; 93(1-2):70-5. PubMed ID: 8804693
    [Abstract] [Full Text] [Related]

  • 10. The caveolin scaffolding domain modifies 2-amino-3-hydroxy-5-methyl-4-isoxazole propionate receptor binding properties by inhibiting phospholipase A2 activity.
    Gaudreault SB, Chabot C, Gratton JP, Poirier J.
    J Biol Chem; 2004 Jan 02; 279(1):356-62. PubMed ID: 14561756
    [Abstract] [Full Text] [Related]

  • 11. Modification of glutamate receptors by phospholipase A2: its role in adaptive neural plasticity.
    Massicotte G.
    Cell Mol Life Sci; 2000 Oct 02; 57(11):1542-50. PubMed ID: 11092449
    [Abstract] [Full Text] [Related]

  • 12. Postsynaptic injection of calcium-independent phospholipase A2 inhibitors selectively increases AMPA receptor-mediated synaptic transmission.
    St-Gelais F, Ménard C, Congar P, Trudeau LE, Massicotte G.
    Hippocampus; 2004 Oct 02; 14(3):319-25. PubMed ID: 15132431
    [Abstract] [Full Text] [Related]

  • 13. Impaired modulation of AMPA receptors by calcium-dependent processes in streptozotocin-induced diabetic rats.
    Chabot C, Massicotte G, Milot M, Trudeau F, Gagné J.
    Brain Res; 1997 Sep 12; 768(1-2):249-56. PubMed ID: 9369322
    [Abstract] [Full Text] [Related]

  • 14. Potassium-induced long-term potentiation in area CA1 of the hippocampus involves phospholipase activation.
    Bernard J, Lahsaini A, Massicotte G.
    Hippocampus; 1994 Aug 12; 4(4):447-53. PubMed ID: 7874236
    [Abstract] [Full Text] [Related]

  • 15. Modulation of the AMPA receptor by phospholipase A2: effect of the antidepressant trimipramine.
    Bernard J, Ohayon M, Massicotte G.
    Psychiatry Res; 1994 Feb 12; 51(2):107-14. PubMed ID: 7912839
    [Abstract] [Full Text] [Related]

  • 16. Strain-related variations of AMPA receptor modulation by calcium-dependent mechanisms in the hippocampus: contribution of lipoxygenase metabolites of arachidonic acid.
    Ménard C, Valastro B, Martel MA, Martinoli MG, Massicotte G.
    Brain Res; 2004 Jun 04; 1010(1-2):134-43. PubMed ID: 15126126
    [Abstract] [Full Text] [Related]

  • 17. The phospholipase A2 inhibitor bromophenacyl bromide prevents the depolarization-induced increase in [3H]AMPA binding in rat brain synaptoneurosomes.
    Bernard J, Lahsaïni A, Baudry M, Massicotte G.
    Brain Res; 1993 Nov 19; 628(1-2):340-4. PubMed ID: 7508812
    [Abstract] [Full Text] [Related]

  • 18. NMDA receptor-mediated regulation of AMPA receptor properties in organotypic hippocampal slice cultures.
    Gellerman DM, Bi X, Baudry M.
    J Neurochem; 1997 Jul 19; 69(1):131-6. PubMed ID: 9202303
    [Abstract] [Full Text] [Related]

  • 19. NMDA-Independent LTP by adenosine A2 receptor-mediated postsynaptic AMPA potentiation in hippocampus.
    Kessey K, Mogul DJ.
    J Neurophysiol; 1997 Oct 19; 78(4):1965-72. PubMed ID: 9325364
    [Abstract] [Full Text] [Related]

  • 20. A novel role for calcium-independent phospholipase A in alpha-amino-3-hydroxy-5-methylisoxazole-propionate receptor regulation during long-term potentiation.
    Martel MA, Patenaude C, Ménard C, Alaux S, Cummings BS, Massicotte G.
    Eur J Neurosci; 2006 Jan 19; 23(2):505-13. PubMed ID: 16420457
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.